Rocket Lab's Next Neutron Milestone Is a Pad Delivery, Not a Launch. I'd Hold Off on Buying the Stock.

Rocket Lab is targeting delivery of its Neutron rocket to the launch pad in Q4 2026, but has not set a launch date after a January tank-test failure delayed the program; the article suggests a first launch could slip into 2027. Q2 revenue rose 62% year over year to a record $234 million, with Q3 guidance of $250 million-$265 million, but adjusted EBITDA is still expected to post a $17 million-$23 million loss. Rocket Lab held $2.4 billion of cash and marketable securities after raising $1.5 billion via stock sales, providing runway for Neutron development but diluting shareholders; profitability and free cash flow are not expected until after Neutron's successful debut, potentially extending into 2028.

Analysis

RKLB is increasingly a duration-and-dilution trade rather than a pure launch-execution trade. The equity is discounting a rapid transition from a low-margin hardware/systems profile into a scaled reusable-launch platform, yet the cash-flow inflection remains materially later than the key engineering milestone. Each additional equity raise protects the development schedule but lowers per-share upside; this creates an asymmetric setup where schedule slippage can compress the multiple well before liquidity becomes a solvency issue.

The more investable near-term question is whether the space-systems franchise can sustain growth and improve gross margin without Neutron. If it can, RKLB earns a higher-quality defense/space-prime valuation floor; if contract mix shifts toward fixed-price government integration work, working-capital demands and program-execution risk could expose that floor. The pending IRDM transaction would add recurring service revenue and potentially reduce cyclicality, but its cash component increases the importance of closing terms, financing sources, and post-deal leverage rather than simply headline strategic fit.

Consensus may underappreciate the distinction between pad delivery and a commercially credible launch cadence. A successful first flight would be sentiment-positive, but qualification, reusability, insurance, customer acceptance, and fleet-capex requirements determine economics over the following 18-24 months. Conversely, a firm launch date accompanied by successful stage qualification could trigger a sharp rerating within 1-3 months because the market is likely assigning a substantial probability to further delay.

Key Decisions for Investors

• Maintain no outright long RKLB ahead of first-stage qualification; revisit on independently verifiable qualification completion plus a firm launch date. A position should be sized as a 2027-28 execution call, not a 2026 earnings trade.
• For existing RKLB exposure, reduce into schedule-driven rallies and use a Q4-2026 pad-delivery miss or absence of a dated launch window as the risk trigger. The key falsifier for a cautious stance is a clean qualification result followed by dated launch operations and no incremental equity issuance.
• Consider a 3-6 month relative-value hedge: long IRDM / short RKLB in equal volatility weights, subject to confirmation of transaction terms and regulatory timetable. IRDM offers recurring service cash flows, while RKLB retains the longer-duration development and dilution exposure; close the pair if deal financing changes materially or the transaction fails.
• Monitor RKLB quarterly for space-systems gross-margin progression, operating cash burn, share-count growth, and backlog conversion. Improving revenue alone is insufficient; sustained margin expansion and lower cash burn before Neutron would invalidate the bearish valuation-duration thesis.